Navigating the Risks and Regulations of Stem Cell Treatments

This chapter explores the controversies surrounding stem cell treatments for arthritis, focusing on their questionable effectiveness and regulatory hurdles faced by the FDA. It details the rapid growth of the industry and the complexities of manufacturers self-identifying their products, along with the FDA's challenges in maintaining oversight.